Market Overview:
The global bioresorbable medical material market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for minimally invasive surgeries, rising prevalence of chronic diseases, and technological advancements in the field of medical devices. Based on type, the global bioresorbable medical material market is segmented into polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, and polycaprolactone (PCL). Of these segments, PLA held the largest share of the global bioresorbable medical material market in 2017. This segment is expected to continue its dominance during the forecast period due to its properties such as high tensile strength and low weight. Based on application, drug delivery held a major share of the global bioresorbable medical material market in 2017 and this trend is projected to continue duringthe forecast period owingtoits benefits such as improved patient compliance rates and reduced dosage errors.
Product Definition:
A bioresorbable medical material is a material that can be broken down by the body's natural processes. This type of material is often used in medical implants, such as screws or plates, because it eliminates the need for later surgery to remove the implant. The importance of bioresorbable medical materials lies in their ability to improve patient care and reduce surgical risks.
Polylactic Acid (PLA):
Polylactic Acid (PLA) is a biodegradable polymer, derived from renewable resources. It has the potential to replace all the conventional plastics on account of its superior properties such as low-density and high thermal stability. PLA is currently used in various applications including medical devices, drug delivery systems and 3D printing filaments.
Polyglycolic Acid (PGA):
Polyglycolic acid (PGA) is a synthetic polymer with an amorphous structure. It has been used as a biocompatible material for tissue engineering and drug delivery applications. PGA is widely used in the manufacturing of bioresorbable medical devices due to its unique properties such as low cytotoxicity, high degradation rate, and controlled release profile.
Application Insights:
Drug delivery dominated the global bioresorbable medical material market in terms of revenue in 2017. The segment is expected to witness significant growth over the forecast period due to increasing product usage for drug delivery applications. Drug-eluting polymers are gaining popularity as they help prevent bioabsorption of drugs by promoting longer retention times and higher blood levels, thereby improving patient compliance.
The orthopedics segment is also estimated to witness lucrative growth during the forecast period owing to rising product penetration for bone repair and reconstruction applications. PCL, PGA, PLA andPGA are some of the most commonly used materials for orthopedic implants as they have excellent mechanical properties such as strength & stiffness along with good biological compatibility which helps reduce inflammation at implant site leading to faster healing process after surgery.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D investments by various companies and rising adoption of bioresorbable products for medical applications in this region. Asia Pacific, on the other hand, is anticipated to witness lucrative growth over the coming years owing to growing healthcare expenditure levels and improving healthcare infrastructure within emerging economies such as India and China. Moreover, rising awareness regarding advanced surgical procedures using bioresorbable materials will drive regional demand further.
Europe was valued at USD X million in 2017 owing to high product demand from several major end-use industries including orthopedics and others that have been experiencing a decline due their limited replacement rate with synthetic polymers across developed regions of Europe such as Germany or U K.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily owing to the increasing preference for less-invasive procedures over traditional open surgery, which leads to shorter hospital stays, faster recoveries, and reduced pain and scarring. Bioresorbable medical materials are ideally suited for use in minimally invasive surgeries as they can be easily delivered through small incisions and then degrade and dissolve over time without leaving any residue or implant behind.
- Growing demand for bioresorbable implants: The global market for bioresorbable implants is expected to grow at a CAGR of 9% from 2016 to 2021. This growth can be attributed to the increasing number of patients requiring implantation procedures due to rising incidence rates of various diseases (e.g., cancer) and growing geriatric population worldwide. Bioresorbable implants offer several advantages over traditional metallic implants such as elimination of the need for second surgery/removal procedure, reduced risk of infection, and decreased patient morbidity & mortality rates post-surgery etc.).
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioresorbable Medical Material Market Research Report
By Type
Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), PLGA
By Application
Drug Delivery, Orthopedics, Others
By Companies
Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med, KLS Martin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
147
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Bioresorbable Medical Material Market Report Segments:
The global Bioresorbable Medical Material market is segmented on the basis of:
Types
Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), PLGA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Delivery, Orthopedics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Evonik
- Corbion
- DSM
- Mitsui Chemicals
- PCAS
- Poly-Med
- KLS Martin
Highlights of The Bioresorbable Medical Material Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polylactic Acid (PLA)
- Polyglycolic Acid (PGA)
- Polysaccharides
- Polycaprolactone (PCL)
- PLGA
- By Application:
- Drug Delivery
- Orthopedics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioresorbable Medical Material Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioresorbable medical material is a type of medical device that can be dissolved or absorbed by the body. This type of device is often used to treat injuries or diseases.
Some of the major companies in the bioresorbable medical material market are Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, Poly-Med, KLS Martin.
The bioresorbable medical material market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioresorbable Medical Material Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioresorbable Medical Material Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioresorbable Medical Material Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioresorbable Medical Material Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioresorbable Medical Material Market Size & Forecast, 2020-2028
4.5.1 Bioresorbable Medical Material Market Size and Y-o-Y Growth
4.5.2 Bioresorbable Medical Material Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polylactic Acid (PLA)
5.2.2 Polyglycolic Acid (PGA)
5.2.3 Polysaccharides
5.2.4 Polycaprolactone (PCL)
5.2.5 PLGA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Drug Delivery
6.2.2 Orthopedics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioresorbable Medical Material Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioresorbable Medical Material Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polylactic Acid (PLA)
9.6.2 Polyglycolic Acid (PGA)
9.6.3 Polysaccharides
9.6.4 Polycaprolactone (PCL)
9.6.5 PLGA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Drug Delivery
9.10.2 Orthopedics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polylactic Acid (PLA)
10.6.2 Polyglycolic Acid (PGA)
10.6.3 Polysaccharides
10.6.4 Polycaprolactone (PCL)
10.6.5 PLGA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Drug Delivery
10.10.2 Orthopedics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polylactic Acid (PLA)
11.6.2 Polyglycolic Acid (PGA)
11.6.3 Polysaccharides
11.6.4 Polycaprolactone (PCL)
11.6.5 PLGA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Drug Delivery
11.10.2 Orthopedics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polylactic Acid (PLA)
12.6.2 Polyglycolic Acid (PGA)
12.6.3 Polysaccharides
12.6.4 Polycaprolactone (PCL)
12.6.5 PLGA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Drug Delivery
12.10.2 Orthopedics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polylactic Acid (PLA)
13.6.2 Polyglycolic Acid (PGA)
13.6.3 Polysaccharides
13.6.4 Polycaprolactone (PCL)
13.6.5 PLGA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Drug Delivery
13.10.2 Orthopedics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioresorbable Medical Material Market: Competitive Dashboard
14.2 Global Bioresorbable Medical Material Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Evonik
14.3.2 Corbion
14.3.3 DSM
14.3.4 Mitsui Chemicals
14.3.5 PCAS
14.3.6 Poly-Med
14.3.7 KLS Martin
